Canadian Imperial Bank of Commerce Forecasts Strong Price Appreciation for Kinaxis (TSE:KXS) Stock

Kinaxis (TSE:KXSGet Free Report) had its price objective boosted by investment analysts at Canadian Imperial Bank of Commerce from C$173.00 to C$205.00 in a research note issued to investors on Friday,BayStreet.CA reports. Canadian Imperial Bank of Commerce’s price target suggests a potential upside of 22.03% from the company’s current price.

Several other brokerages have also recently commented on KXS. TD Securities reduced their target price on shares of Kinaxis from C$229.00 to C$200.00 and set a “buy” rating for the company in a report on Friday, March 6th. BMO Capital Markets increased their target price on shares of Kinaxis from C$180.00 to C$185.00 in a report on Friday, May 8th. Canaccord Genuity Group reduced their target price on shares of Kinaxis from C$225.00 to C$200.00 in a report on Friday, March 6th. Royal Bank Of Canada increased their target price on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an “outperform” rating in a report on Friday, May 8th. Finally, Stifel Nicolaus dropped their price target on shares of Kinaxis from C$245.00 to C$200.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Six analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of C$200.00.

Read Our Latest Report on Kinaxis

Kinaxis Stock Up 0.1%

Shares of Kinaxis stock traded up C$0.18 on Friday, hitting C$167.99. The company had a trading volume of 66,220 shares, compared to its average volume of 137,574. Kinaxis has a twelve month low of C$117.22 and a twelve month high of C$212.45. The stock has a 50-day moving average of C$144.71 and a 200-day moving average of C$150.38. The firm has a market capitalization of C$4.59 billion, a P/E ratio of 57.14, a P/E/G ratio of 3.60 and a beta of 0.68. The company has a debt-to-equity ratio of 12.15, a current ratio of 1.72 and a quick ratio of 2.29.

Kinaxis (TSE:KXSGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported C$1.45 EPS for the quarter. Kinaxis had a net margin of 14.48% and a return on equity of 19.72%. The business had revenue of C$230.19 million during the quarter. Research analysts predict that Kinaxis will post 4.2526231 earnings per share for the current year.

Insider Buying and Selling at Kinaxis

In other Kinaxis news, insider Conrad John Mandala sold 924 shares of the company’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of C$137.14, for a total transaction of C$126,717.36. Following the sale, the insider directly owned 820 shares of the company’s stock, valued at approximately C$112,454.80. This represents a 52.98% decrease in their ownership of the stock. Also, Director Robert G. Courteau sold 5,010 shares of the company’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the sale, the director directly owned 32,945 shares in the company, valued at C$4,987,543.55. This trade represents a 13.20% decrease in their ownership of the stock. Insiders have sold 35,934 shares of company stock worth $5,328,181 over the last ninety days. Insiders own 1.20% of the company’s stock.

About Kinaxis

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.

See Also

Analyst Recommendations for Kinaxis (TSE:KXS)

Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.